Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carl Bernard Ziegler is active.

Publication


Featured researches published by Carl Bernard Ziegler.


Bioorganic & Medicinal Chemistry Letters | 2001

Synthesis and structure-activity relationships of thiotetronic acid analogues of thiolactomycin

Subas M. Sakya; Melani Suarez-Contreras; John P. Dirlam; Thomas N. O'Connell; Shigeru F. Hayashi; Sheryl L. Santoro; Barbara J. Kamicker; David M. George; Carl Bernard Ziegler

3-Acetyl analogues of thiolactomycin, a thiotetronic acid natural product, were synthesized and profiled against livestock pathogens. Some analogues showed improved activity over thiolactomycin against Staphylococcus aureus and comparable activity against Pasteurella multocida. Several semisynthetically modified analogues of thiolactomycin showed no improvement in activity over thiolactomycin.


Bioorganic & Medicinal Chemistry Letters | 2002

Synthesis and SAR of azalide 3,6-ketal aromatic derivatives as potent gram-positive and gram-negative antibacterial agents

Hengmiao Cheng; John P. Dirlam; Carl Bernard Ziegler; Kristin Marie Lundy; Shigeru F. Hayashi; Barbara J. Kamicker; Jason K. Dutra; Kirsten L. Daniel; Sheryl L. Santoro; David M. George; Camilla D. Bertsche; Subas M. Sakya; Melani Suarez-Contreras

3,6-Ketals of 15-membered azalide pseudoaglycones are a novel series of macrolide antibiotics. The aromatic derivatives of the azalide 3,6-ketals demonstrated potent antibacterial activities against both Gram-positive and Gram-negative bacteria.


Bioorganic & Medicinal Chemistry Letters | 2003

Azalide 3,6-Ketals: antibacterial activity and structure–Activity relationships of aryl and hetero aryl substituted analogues

Subas M. Sakya; Peter Bertinato; Bryan Pratt; Melani Suarez-Contreras; Kristin Marie Lundy; Martha L. Minich; Hengmiao Cheng; Carl Bernard Ziegler; Barbara J. Kamicker; Shigeru F. Hayashi; Sheryl L. Santoro; David M. George; Camilla D. Bertsche

Aryl and hetero aryl substituted 3,6-ketals of 15-membered azalide analogues were synthesized and were found to have potent in vitro antibacterial activity against veterinary pathogens, including Staphylococcus aureus and Pasteurella multocida.


Bioorganic & Medicinal Chemistry Letters | 2006

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog

Subas M. Sakya; Kristin Lundy DeMello; Martha L. Minich; Bryson Rast; Andrei Shavnya; Robert J. Rafka; David A. Koss; Hengmiao Cheng; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Lisa A. Lund; Suzanne H. St. Denis; Anne Hickman; Michelle L. Haven; Michael P. Lynch


Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.

Hengmiao Cheng; Kristin Lundy DeMello; Jin Li; Subas M. Sakya; Kazuo Ando; Kiyoshi Kawamura; Tomoki Kato; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Rod Stevens; Lisa A. Lund; Donald W. Mann; Carolyn Rose Kilroy; Michelle L. Haven; Erik L. Nimz; Jason K. Dutra; Chao Li; Martha L. Minich; Nicole L. Kolosko; Carol F. Petras; Annette M. Silvia; Scott B. Seibel


Bioorganic & Medicinal Chemistry Letters | 2004

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.

Jin Li; Kristin Lundy DeMello; Henry Cheng; Subas M. Sakya; Brian Scott Bronk; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Carolyn Rose Kilroy; Donald W. Mann; Eric L. Nimz; Michael P. Lynch; Michelle L. Haven; Nicole L. Kolosko; Martha L. Minich; Chao Li; Jason K. Dutra; Bryson Rast; Rhonda Marie Crosson; Barry James Morton; Glen W. Kirk; Kathleen M. Callaghan; David A. Koss; Andrei Shavnya; Lisa A. Lund; Scott B. Seibel; Carol F. Petras; Annette M. Silvia


Archive | 2005

Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene

Carl Bernard Ziegler; Barbara Alice Johnson


Archive | 2005

Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline

Carl Bernard Ziegler; Barbara Alice Johnson


Archive | 2005

Process for Forming Amorphous Atorvastatin

Antone John Debettencourt; Peter Robert Rose; Evgenyi Y. Shalaev; George J. Quallich; Carl Bernard Ziegler


Archive | 1999

13-membered azalides and their use as antibiotic agents

Robert J. Rafka; Barry James Morton; Colman Brendan Ragan; Peter Bertinato; John P. Dirlam; Alan Elwood Blize; Carl Bernard Ziegler

Collaboration


Dive into the Carl Bernard Ziegler's collaboration.

Researchain Logo
Decentralizing Knowledge